SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Merck ADC Drug Cuts Death Risk 32% in Advanced Endometrial Cancer

Merck’s antibody-drug conjugate reduced the risk of death by 32% among patients with advanced endometrial cancer.

MRK

Related stories